Skip to main content
. 2009 Nov 18;4:425–433. doi: 10.2147/cia.s6738
Content of the guideline Y N N/A
1 Does the guideline mention claudication?
2 Does the guideline mention cognitive impairment? If no, skip to 3.
2a
  • If yes to 2, does the guideline discuss how to screen for cognitive impairment?

3 Does the guideline mention renal function? If no, skip to 4.
3a
  • If yes to 3, does the guideline discuss how to screen for renal function?

4 Does the guideline discuss target organ damage? If no, skip to 5.
4a
  • If yes to 4, does the guidelines mention cognitive impairment as an aspect of target organ damage?

5 Does the guidelines include outcomes? If no, skip to 6.
5a
  • If yes to 5, does the guideline mention claudication as an outcome?

  • If yes to 5, does the guideline mention cognitive impairment as an outcome?

  • If yes to 5, does the guideline mention renal function as an outcome?

6 Does the guideline cite evidence for outcomes that are likely to benefit from the recommended management? If no, skip to 7.
6a
  • If so, does the guideline cite evidence or otherwise suggest that cognition is likely to benefit from the recommended management?

7 Are recommendations made for ongoing monitoring of the principle condition and complications? If no, skip to 8.
7a
  • If so, do these recommendations include assessment of cognition?

8 Was cognition mentioned as a risk factor (exposure) for any vascular outcome? If no, skip to 9.